Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compound heterozygotes in hyperphenylalaninaemia.

K Bartholomé, K Olek, F Trefz

    Human Genetics
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    European guidelines on diagnosis and treatment of phenylketonuria: First revision.

    Molecular genetics and metabolism·2025
    Same author

    Patient's thoughts and expectations about centres of expertise for PKU.

    Orphanet journal of rare diseases·2021
    Same author

    Correction to: PKU dietary handbook to accompany PKU guidelines.

    Orphanet journal of rare diseases·2020
    Same author

    Method to characterize a thermal diode in saturated steam atmosphere.

    The Review of scientific instruments·2020
    Same author

    PKU dietary handbook to accompany PKU guidelines.

    Orphanet journal of rare diseases·2020
    Same author

    The complete European guidelines on phenylketonuria: diagnosis and treatment.

    Orphanet journal of rare diseases·2017
    Same journal

    A novel pathogenic synonymous DHCR7 variant unveiled by aberrant splicing in Smith-Lemli-Opitz syndrome.

    Human genetics·2026
    Same journal

    Blending borders: reconstructing the genetic history of the Sindhi population.

    Human genetics·2026
    Same journal

    Within-sibling attenuation of polygenic risk score accuracy: investigating the effects of principal component analysis, LD score regression, and mixed model association in the UK Biobank.

    Human genetics·2026
    Same journal

    Long-read genome sequencing resolves a de novo complex 18q12.1q21.2 triplication causing partial tetrasomy and reveals its underlying mechanism.

    Human genetics·2026
    Same journal

    A genetic variant of adenylate cyclase 7 associated with ulcerative colitis shows impaired function and G-protein-coupled receptor signaling.

    Human genetics·2026
    Same journal

    AI in variant analysis: fast track to genetic diagnoses.

    Human genetics·2026
    See all related articles

    Most patients with moderately high phenylalanine levels are compound heterozygotes for hyperphenylalaninaemia and phenylketonuria. Genetic testing can clarify these complex genotypes in affected families.

    Area of Science:

    • Biochemistry
    • Genetics
    • Metabolic Disorders

    Background:

    • Hyperphenylalaninaemia is a metabolic disorder characterized by elevated phenylalanine levels.
    • Phenylketonuria is a severe form of hyperphenylalaninaemia requiring dietary management.
    • Understanding the genetic basis of these conditions is crucial for diagnosis and treatment.

    Observation:

    • The study presents three children diagnosed with hyperphenylalaninaemia and their affected mothers.
    • Genetic analysis revealed at least one child as a compound heterozygote for hyperphenylalaninaemia and phenylketonuria.
    • Family members underwent L-phenylalanine loading tests and phenylalanine hydroxylase determination.

    Findings:

    • Most patients exhibiting moderately elevated serum phenylalanine levels possess a hyperphenylalaninaemia/phenylketonuria genotype.

    Related Experiment Videos

  • These individuals are typically compound heterozygotes, inheriting different mutations from each parent.
  • Diagnostic tests like phenylalanine loading and enzyme assays are key to identifying these genotypes.

    • Implications:

    • Accurate genetic diagnosis is essential for managing patients with hyperphenylalaninaemia and phenylketonuria.
    • Identifying compound heterozygotes allows for tailored genetic counseling and potential therapeutic strategies.
    • This research refines our understanding of the genetic spectrum of hyperphenylalaninaemia, impacting clinical practice.